Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e fold » _ fold (Expand Search), 5 fold (Expand Search), 2 fold (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e fold » _ fold (Expand Search), 5 fold (Expand Search), 2 fold (Expand Search)
-
1621
-
1622
-
1623
Nilotinib decreases the <i>in vitro</i> tumorigenicity of HEI-193 cells.
Published 2013“…(C) The mean maximal colony diameter was decreased by nilotinib at ≥3 µM in PDGF-BB media, and at ≥5 µM in GM. …”
-
1624
-
1625
-
1626
-
1627
Inhibition of MRP1 significantly decreases basal and apoptotic GSH efflux.
Published 2012“…GSH release from MRP1-silenced ARPE-19 cells incubated with 150 µM H<sub>2</sub>O<sub>2</sub> for 5 h in serum free medium. A significant decrease (P<0.001 vs scrambled control) in GSH release was observed in 5 h. …”
-
1628
-
1629
Mesothelin expression and RG7787 uptake is decreased in KLM-1-R.
Published 2015“…<p><b>A</b>: Surface mesothelin levels are 5-fold lower in resistant KLM-1 (KLM-1-R) compared to KLM-1. …”
-
1630
-
1631
-
1632
-
1633
-
1634
L-NNA treatment decreases tumor blood flow and increases hypoxia.
Published 2013“…Data presented as mean intensity as a percentage of control ± SEM; n = 5; *** = p<0.01. …”
-
1635
-
1636
-
1637
-
1638
SH-11052 decreases the expression of NF-κB target genes.
Published 2014“…(C) qRT-PCR using TaqMan probes showed that mRNA levels of NF-κB target genes <i>IL8</i> (interleukin-8) (<i>left panel</i>), <i>CCL2</i> (MCP-1) and <i>PTGS2</i> (COX2) (<i>right panel</i>), all induced by TNF-α, were decreased in the presence of <b>2</b> in a dose dependent manner. …”
-
1639
-
1640